Update on Targets of Biologic Therapies for Rheumatoid Arthritis.
about
Butrin, isobutrin, and butein from medicinal plant Butea monosperma selectively inhibit nuclear factor-kappaB in activated human mast cells: suppression of tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8ADAMTS-7 forms a positive feedback loop with TNF-α in the pathogenesis of osteoarthritis.Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity.Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected].Endoplasmic reticulum stress induces the expression of COX-2 through activation of eIF2α, p38-MAPK and NF-κB in advanced glycation end products stimulated human chondrocytes.Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes.The impact of biologic response modifiers on hepatitis B virus infection.Therapeutic targets for rheumatoid arthritis: Progress and promises.Iguratimod for the treatment of rheumatoid arthritis in Japan.Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells.Progranulin protects against osteoarthritis through interacting with TNF-α and β-Catenin signalling.Ginsenoside Rg1 attenuates adjuvant-induced arthritis in rats via modulation of PPAR-γ/NF-κB signal pathwayEvaluation of the Efficacy of Combined Therapy of Methotrexate and Etanercept versus Methotrexate as a Mono-Therapy.Functional role of human interleukin-32 and nuclear transcription factor-kB in patients with psoriasis and psoriatic arthritis.
P2860
Q33861973-03857B44-0B5C-4973-B215-12005B20F8C3Q34362788-C754764D-40BB-4DC4-B508-91ECE68BAA7AQ35126225-B909E320-BEBF-42C2-899D-E1C31F50BC16Q35135845-F903805A-4E02-4227-902A-051F9B9CFDB3Q35875201-BD80CC82-2DF0-4914-A929-52D2054DB5D5Q37270775-49CD9B25-FBB4-46DE-93DE-C3CC78BADA97Q37832503-CAEF87DA-180D-405A-B469-D1DDD7287890Q38179461-F63A1582-8F52-4F16-8694-2FE1882F3695Q38386610-90B041BA-B0F3-4C4D-97C6-81452A60B5C2Q39897321-AF591B9B-8484-4CCB-A31A-D94654910531Q39918340-A4EDBA2F-E117-40DE-A199-F586FAB9AD9FQ41548524-D073E550-2C3D-4F8D-92D3-FB5910FD7724Q54960379-9C38611A-0586-4DF1-AC93-2C92A0095554Q55163181-7F4DF97C-3E7B-4DDD-A807-5CFA07A94D91
P2860
Update on Targets of Biologic Therapies for Rheumatoid Arthritis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Update on Targets of Biologic Therapies for Rheumatoid Arthritis.
@en
Update on Targets of Biologic Therapies for Rheumatoid Arthritis.
@nl
type
label
Update on Targets of Biologic Therapies for Rheumatoid Arthritis.
@en
Update on Targets of Biologic Therapies for Rheumatoid Arthritis.
@nl
prefLabel
Update on Targets of Biologic Therapies for Rheumatoid Arthritis.
@en
Update on Targets of Biologic Therapies for Rheumatoid Arthritis.
@nl
P2860
P1476
Update on Targets of Biologic Therapies for Rheumatoid Arthritis
@en
P2093
Tariq M Haqqi
P2860
P356
10.2174/157339708786263915
P577
2008-11-01T00:00:00Z